Main therapeutics instituted during ICU stay, evolution of severity scores, and occurrence of complications are reported Table 2 . The most significant differences between the two groups of patients were the more frequent use of drotrecogin alpha, intensive insulin therapy and hydrocortisone in Group B patients.